SCHEMBL8612145

SCHEMBL8612145

O=C(O)CCNc1ccc(C(F)(F)F)cc1[N+](=O)[O-]

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 13/20 0.63
SMN1; SMN2 Q16637 4/20 0.63
RAB9A P51151 2/20 0.63
NPC1 O15118 1/20 0.63
GAA P10253 4/20 0.62
HTT P42858 4/20 0.61
LMNA P02545 5/20 0.60
KMT2A Q03164 4/20 0.60
MEN1 O00255 3/20 0.60
THRB P10828 1/20 0.60
POLB P06746 1/20 0.60
PKM P14618 1/20 0.60
ALDH1A1 P00352 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
STAT3 P40763 1/20 0.56
ALOX12 P18054 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5113536 0.86 KMT2A (0.70) MAPTSMN1; SMN2RAB9ANPC1GAA
SCHEMBL5113527 0.86 KMT2A (0.70) MAPTSMN1; SMN2RAB9ANPC1GAA
SCHEMBL29392652 0.85 GAA (0.67) MAPTSMN1; SMN2RAB9ANPC1GAA
SCHEMBL112411 0.85 GAA (0.67) MAPTSMN1; SMN2RAB9ANPC1GAA
SCHEMBL8609704 0.83 MAPT (0.62) MAPTSMN1; SMN2RAB9ANPC1GAA
SCHEMBL11199799 0.83 MAPT (0.68) MAPTSMN1; SMN2RAB9ANPC1GAA
SCHEMBL4695415 0.82 HCAR3 (0.52) MAPTHTTKMT2APOLBPKM
SCHEMBL5704002 0.82 GAA (0.67) MAPTSMN1; SMN2RAB9ANPC1GAA
SCHEMBL116088 0.82 GAA (0.70) MAPTSMN1; SMN2RAB9ANPC1GAA
SCHEMBL30697332 0.82 HCAR3 (0.52) MAPTHTTKMT2APOLBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5852017-A 2,3(1H,4H)-quinoxalinediones BASF AKTIENGESELLSCHAFT (DE) 1998-12-22 US disclosed
EP-0572852-B1 Quinoxalin-2,3(1H,4H)-diones used as medicine BASF AG (DE) 1998-10-21 EP disclosed
US-5714489-A 2,3(1H,4H)quinoxalinedione BASF AKTIENGESELLSCHAFT (DE) 1998-02-03 US disclosed
EP-0572852-A1 Quinoxalin-2,3(1H,4H)-diones used as medicine BASF Aktiengesellschaft (DE) 1993-12-08 EP disclosed